Denali Therapeutics shares owned by Defilade Capital Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Defilade Capital Management
from 13F filings
Historical chart of Defilade Capital Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Defilade Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $26M | 1.4M | 19.20 |
More positions owned by Defilade Capital Management
View all positions for Defilade Capital Management